Invitation to presentation of RaySearch’s interim report for the third quarter of 2024
STOCKHOLM, Oct. 21, 2024 /PRNewswire/ -- Analysts, investors, and the media are invited to a presentation of RaySearch's interim report...
Month: October 2024
LINDIS Biotech Receives Positive CHMP Opinion for KORJUNY(R) (catumaxomab) in the European Union
Upon authorization by the European Commission, KORJUNY® will be the only drug approved and available for the intraperitoneal treatment of...
Nomination Committee Appointed for Spago Nanomedical’s Annual General Meeting 2025
LUND, SE / ACCESSWIRE / October 21, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) In accordance with the instructions to the nomination...
Relief Therapeutics Receives Notice of Allowance for European Patent Covering RLF-TD011 for Epidermolysis Bullosa Wound Treatment
GENEVA, SWITZERLAND / ACCESSWIRE / October 21, 2024 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief, or the Company), a...
Exploratory Mindset Drives Insights at HLTH 2024: Black Book Poll Reveals Attendees Prioritizing Learning Over Immediate Investments
Survey reveals attendees are postponing AI and IT initiatives as budget constraints shift focus to internal system challenges, with unproven...
Global Health Exhibition Opens its Doors Tomorrow to Record-Breaking 100,000+ Attendees to World’s Premier Healthcare Transformation Event
Kingdom of Saudi Arabia opens the Global Health Exhibition (21-23 October 2024) tomorrow, a major international healthcare event with 100,000+...
Lena Esmail Advocates for Expanding Healthcare Access in Underserved Communities: A Call to Support QuickMed’s Innovative Approach
Lena Esmail is a healthcare innovator and the CEO of QuickMed, which she founded in 2018. YOUNGSTOWN, OH / ACCESSWIRE...
Kaia Health Appoints Adam Pellegrini as Global CEO And Launches The First Digital Pulmonary Rehab Program In Partnership With The COPD Foundation
NEW YORK, Oct. 19, 2024 /PRNewswire/ -- Kaia Health (Kaia), a leading digital health company, announces the appointment of Adam...
Investors in Common Stock and Certain Debt Securities Offered by Valeant Pharmaceuticals International, Inc. May be Entitled to Payment from an SEC Fair Fund
WASHINGTON, Oct. 19, 2024 /PRNewswire/ -- The following statement is being issued regarding the Valeant Pharmaceuticals Fair Fund. UNITED STATES SECURITIES...
New Clinical Study Confirms the Industry Leading Performance Of Senzime’s TetraGraph System
UPPSALA, SWEDEN / ACCESSWIRE / October 19, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Philadelphia, ANESTHESIOLOGY 2024 - A just published US-based study...
KFSHRC Pioneers Cancer Treatment with Breakthrough Therapies and Exceptional Outcomes
RIYADH, Saudi Arabia, Oct. 19, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is revolutionizing cancer...
Nurix Therapeutics Presents Positive Results from the Ongoing Clinical Trial of Its BTK Degrader NX-5948 in Patients with Relapsed/Refractory Waldenstrom’s Macroglobulinemia
NX-5948 demonstrated robust clinical activity with objective responses observed in 7 of 9 (77.8%) evaluable Waldenstrom’s patients in the ongoing...
NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS)
SAN DIEGO, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing...
Tevogen CEO Expresses Gratitude for Unprecedented Public Support of Company’s Business Model of Commercial Success Through Patient Accessibility and Reaffirms His Commitment to Share Additional Details in the Coming Days
WARREN, N.J., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN) is a...
Celularity Inc. Receives Notice from Nasdaq; Confirms Intention to File an Appeal
FLORHAM PARK, N.J., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”), a regenerative medicine company developing and commercializing...
Three-year Results for EYLEA HD® (aflibercept) Injection 8 mg Demonstrate Continued Durable Vision Gains and Anatomic Improvements with Extended Dosing Intervals in Patients with Diabetic Macular Edema
88% of EYLEA HD patients had a last assigned dosing interval of ≥12 weeks at week 156, while sustaining visual...
Roche’s Vabysmo improved vision in underrepresented populations with diabetic macular edema (DME) in a first-of-its-kind study
The ELEVATUM study showed clinically meaningful improvement in vision and reduction in retinal fluid in people with diabetic macular edema...
Curio Digital Therapeutics Applauded by Frost & Sullivan for Enhancing Women’s Maternal Mental Healthcare with its MamaLift and MamaLift Plus Solutions
MamaLift ensures personalized care tailored to each woman's journey through motherhood, empowering them to manage stress, embrace joy, and reduce...
Berman Tabacco Announces that it has Filed a New Class Action Complaint Against Outset Medical, Inc. with an Expanded Class Period
BOSTON--(BUSINESS WIRE)--#classaction--Berman Tabacco announces that it has filed a securities class action complaint in the United States District Court for...
New York City Medical Malpractice Law Firm ASK4SAM Expands Focus on Brooklyn, Bronx Delayed Cancer & Stroke Diagnosis Cases
Garden City, New York--(Newsfile Corp. - October 18, 2024) - Silberstein, Awad & Miklos, P.C. (ASK4SAM), a leading personal injury...